We utilised a 1:1 propensity matching strategy to establish comparable groups of patients treated with different glucose-lowering drugs, including GLP-1RA, SGLT2 inhibitors and metformin
Iron metabolism and toxicity
Which medicines are covered The PAP only covers a specific list of Novo Nordisk registered trademark medicines, which currently includes certain GLP-1 medications (Ozempic, Rybelsus and Xultophy), insulin products (Fiasp, Novolin R, Novolin N and Novolin 70/30, NovoLog Vial, NovoLog PenFill and Flexpen, NovoLog Mix, Tresiba), devices (Novopen, NovoFine), and other selected specialty therapies
The inclusion of B vitamins and magnesium in IV therapy helps combat fatigue and restore energy
You may have heard of the Hollywood Diet, a new, effective option, commonly referred to as weight loss shots
Cell Physiol Biochem 44:763777